Endometriosis: cannabidiol therapy for symptom relief
This review examines data from patient samples and animal models on endometriosis pathophysiology and the potential of cannabidiol (CBD) formulations for symptom relief, considering pharmacokinetics and ongoing clinical trials.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (91)
- Animal models of endometriosis: Replicating the aetiology and symptoms of the human disorder via openalex
- A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment via openalex
- Association Between Nociplastic Pain and Pain Severity and Impact in Women With Chronic Pelvic Pain via openalex
- Cannabis for endometriosis‐related pain and symptoms: It's high time that we see this as a legitimate treatment via openalex
- Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey via openalex
- CCL18 promotes endometriosis by increasing endometrial cell migration and neuroangiogenesis via openalex
- Central changes associated with chronic pelvic pain and endometriosis via openalex
- Current developments in endometriosis-associated pain via openalex
- Detection of Cannabinoid Receptor Expression by Endometriotic Lesions in Women with Endometriosis as an Alternative to Opioid-Based Pain Medication via openalex
- Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain via openalex
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms via openalex
- Elevated Peritoneal Expression and Estrogen Regulation of Nociceptive Ion Channels in Endometriosis via openalex
- Endometriosis-associated chronic pelvic pain via openalex
- Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management via openalex
- Functional Connectivity Is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain via openalex
- Genomic characterisation of the overlap of endometriosis with 76 comorbidities identifies pleiotropic and causal mechanisms underlying disease risk via openalex
- Identification and Quantification of Dopamine Receptor 2 in Human Eutopic and Ectopic Endometrium: A Novel Molecular Target for Endometriosis Therapy1 via openalex
- Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis via openalex
- Local upregulation of transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 ion channels in rectosigmoid deep infiltrating endometriosis via openalex
- Macrophage‐derived insulin‐like growth factor‐1 is a key neurotrophic and nerve‐sensitizing factor in pain associated with endometriosis via openalex
- Macrophages inhibit and enhance endometriosis depending on their origin via openalex
- New concepts on the etiology of endometriosis via openalex
- Pathogenesis of endometriosis: Look no further than John Sampson via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- PPARγ Agonists: Emergent Therapy in Endometriosis via openalex
- Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain via openalex
- Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications via openalex
- Self-management strategies amongst Australian women with endometriosis: a national online survey via openalex
- Synthetic Cannabinoid Agonist WIN 55212-2 Targets Proliferation, Angiogenesis, and Apoptosis via MAPK/AKT Signaling in Human Endometriotic Cell Lines and a Murine Model of Endometriosis via openalex
- The Place of Cannabinoids in the Treatment of Gynecological Pain via openalex
- Use of dopamine agonists to target angiogenesis in women with endometriosis via openalex
- What Have We Learned from Animal Models of Endometriosis and How Can We Use the Knowledge Gained to Improve Treatment of Patients? via openalex
- W4317434652 via openalex
- W4319333596 via openalex
- W4324020469 via openalex
- W4324387366 via openalex
- W4353015427 via openalex
- W4361217162 via openalex
- W4362666030 via openalex
- W4376121547 via openalex
- W4380537574 via openalex
- W4383100275 via openalex
- W4384565166 via openalex
- W4385416492 via openalex
- W4385697503 via openalex
- W4386101777 via openalex
- W4386116778 via openalex
- W4386249423 via openalex
- W4394962814 via openalex
- W4396706993 via openalex
- W4396830236 via openalex
- W4396873961 via openalex
- W4400652151 via openalex
- W4401716056 via openalex
- W4402206296 via openalex
- W6846860059 via openalex
- W6852424734 via openalex
- W6857681899 via openalex
- W1644289333 via openalex
- W6873427920 via openalex
- W1968591685 via openalex
- W2006503897 via openalex
- W2113421289 via openalex
- W2756282134 via openalex
- W2930559544 via openalex
- W2951933276 via openalex
- W2962828254 via openalex
- W3040679668 via openalex
- W3082866670 via openalex
- W3092324413 via openalex
- W3103002655 via openalex
- W3106550468 via openalex
- W3108056904 via openalex
- W3109062651 via openalex
- W3134384001 via openalex
- W3134885188 via openalex
- W3165294846 via openalex
- W3174330972 via openalex
- W3185888119 via openalex
- W3196785030 via openalex
- W3197127499 via openalex
- W3197677315 via openalex
- W4206755368 via openalex
- W4210757569 via openalex
- W4224731113 via openalex
- W4225133301 via openalex
- W4229374520 via openalex
- W4281676448 via openalex
- W4287835672 via openalex
- W4306772736 via openalex
- W4309658164 via openalex
Cited by (3)
- Cannabidiol-Enriched Extract Oil for Postoperative Management of Chronic Pelvic Pain Secondary to Endometriosis: A Randomized Clinical Trial—DREAMLAND Study 2026
- Project Twenty21 Australia: A Case Study of the Treatment of Chronic Pelvic Pain Due To Endometriosis with Cannabidiol Oil 2025
- Pharmacological management of endometriosis pain 2025
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-16T00:32:02.878706+00:00